Interventional Glaucoma

Latest News


CME Content


The prevalence of open-angle glaucoma varies by ethnicity. There are also ethnic-related variations in structural characteristics of normal eyes.

Bausch + Lomb has initiated its phase III clinical program of latanoprostene bunod (licensed by Nicox S.A.) for the reduction of IOP in glaucoma or ocular hypertension.